Trinity Biotech Plc (TRIB)
6.04
-0.71
(-10.52%)
USD |
NASDAQ |
Oct 08, 16:00
6.11
+0.07
(+1.16%)
After-Hours: 20:00
Trinity Biotech Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 105.16M |
| September 30, 2025 | 103.71M |
| June 30, 2025 | 99.63M |
| March 31, 2025 | 99.79M |
| December 31, 2024 | 103.29M |
| September 30, 2024 | 97.45M |
| June 30, 2024 | 94.36M |
| March 31, 2024 | 90.30M |
| December 31, 2023 | 59.44M |
| September 30, 2023 | 63.60M |
| June 30, 2023 | 71.99M |
| March 31, 2023 | 91.16M |
| December 31, 2022 | 92.10M |
| September 30, 2022 | 97.90M |
| June 30, 2022 | 107.14M |
| March 31, 2022 | 106.10M |
| December 31, 2021 | 118.90M |
| September 30, 2021 | 122.78M |
| June 30, 2021 | 124.72M |
| March 31, 2021 | 135.98M |
| December 31, 2020 | 130.40M |
| September 30, 2020 | 136.08M |
| June 30, 2020 | 128.73M |
| March 31, 2020 | 129.13M |
| December 31, 2019 | 131.07M |
| Date | Value |
|---|---|
| September 30, 2019 | 173.25M |
| June 30, 2019 | 171.70M |
| March 31, 2019 | 172.65M |
| December 31, 2018 | 151.66M |
| September 30, 2018 | 183.33M |
| June 30, 2018 | 194.45M |
| March 31, 2018 | 194.68M |
| December 31, 2017 | 192.97M |
| September 30, 2017 | 244.62M |
| June 30, 2017 | 244.80M |
| March 31, 2017 | 245.14M |
| December 31, 2016 | 250.97M |
| September 30, 2016 | 360.47M |
| June 30, 2016 | 357.77M |
| March 31, 2016 | 360.04M |
| December 31, 2015 | 363.68M |
| September 30, 2015 | 355.38M |
| June 30, 2015 | 359.76M |
| March 31, 2015 | 246.78M |
| December 31, 2014 | 235.52M |
| September 30, 2014 | 227.90M |
| June 30, 2014 | 238.45M |
| March 31, 2014 | 228.92M |
| December 31, 2013 | 226.49M |
| September 30, 2013 | 222.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 267.36M |
| Akari Therapeutics Plc | 38.62M |
| Autolus Therapeutics Plc | 493.23M |
| Evaxion AS | 19.38M |
Total Assets (Quarterly) Related Metrics
| Debt to Equity Ratio | -1.917 |
| Current Ratio | 0.2542 |
| Net Debt Paydown Yield | 192.2% |